Severe weakness of the respiratory muscles, with attendant respiratory failure and death, has been documented in sepsis. In this study, we show that during murine pulmonary infection with Pseudomonas aeruginosa, multiple pro-inflammatory genes are upregulated not only within the lungs, but also within the diaphragm. Significant induction of TNF-", IL-1", IL-1$, IL-6 and IL-18 gene expression occurred within the diaphragm in a bacterial dose-dependent manner. We determined whether the anti-inflammatory cytokine IL-10 could blunt pro-inflammatory gene expression within the diaphragm under these conditions. The IL-10 receptor was found to be expressed by the diaphragm in vivo as well as in primary diaphragmatic muscle cell cultures. Transduction of myoblasts with an adenoviral vector (Ad-IL-10) induced strong IL-10 expression, and intramuscular injection of the same vector in vivo produced significant increases in IL-10 serum levels. Ad-IL-10 treatment of mice infected with P. aeruginosa significantly inhibited the induction of pro-inflammatory cytokines within the diaphragm, but not in the infected lungs. Ad-IL-10 treatment also led to greatly improved diaphragmatic force production in infected mice. These results suggest that pulmonary infection triggers pro-inflammatory gene expression by the diaphragm along with diaphragmatic weakness. Shifting the balance between pro-and anti-inflammatory mediators in favor of the latter by IL-10 gene delivery was able to restore normal diaphragmatic forcegenerating capacity under these conditions, suggesting a possible avenue for therapeutic intervention.
INTRODUCTION
The diaphragm is the primary muscle of respiration. Impaired contractility of the diaphragm, leading to respiratory failure and death, is well-documented in animal models of sepsis (1) . Sepsis is characterized by a systemic inflammatory response of the host to severe infection (2) , which is mediated in large part through the production of pro-inflammatory effector molecules. Respiratory failure is a major clinical manifestation of sepsis, which greatly contributes to the high mortality associated with this condition (3) . To date, most investigations of respiratory muscle dysfunction in sepsis have been performed in models involving high-dose endotoxin administration. We have recently reported that severe diaphragmatic weakness also occurs during a more low-grade and sustained form of Gramnegative infection, caused by instillation of Pseudomonas aeruginosa organisms into mouse lungs (4) .
P. aeruginosa is one of the most common causes of nosocomial pneumonia, and is also a major source of morbidity and mortality in patients with chronic lung diseases such as cystic fibrosis.
There is considerable evidence that diaphragmatic weakness and wasting are induced by a number of pro-inflammatory mediators, including reactive oxygen species (5), nitric oxide (NO) (6), TNF-" (7) (8) (9) , and IL-6 (10). These pro-inflammatory mediators have the potential to cause muscle weakness via several pathways, such as stimulation of muscle cell protein loss (11, 12) , interference with insulin receptor signaling (13) , and direct depression of excitation-contraction coupling (14) or myofilament function (15) . In addition to such pro-inflammatory mediators, anti-inflammatory effector molecules are also activated during sepsis. Indeed, the systemic and tissue equilibrium between proinflammatory and anti-inflammatory effector molecules is an important determinant of the final clinical outcome in septic patients (16) . IL-10 is probably the most well-established of the anti-inflammatory cytokines, and was originally termed cytokine synthesis inhibitory factor (17) . IL-10 exerts its antiinflammatory effects via several complex mechanisms including inhibition of cytokine expression (18, 19) , interference with antigen presentation (20) , and suppression of costimulatory molecules (21) . In animal models of endotoxemia, IL-10 can inhibit the expression of pro-inflammatory cytokines such as TNF-" and IL-6 in the lung and serum (22) , as well as reduce mortality (23) .
In the present study, we hypothesized that pulmonary infection with P. aeruginosa would lead to significant upregulation of pro-inflammatory effector molecules in the diaphragm, and that this would occur in a bacterial dose-dependent manner. In a previous study performed by our group, diaphragmatic contractility was greatly impaired during P. aeruginosa lung infection, whereas limb muscle function was unaffected (4) . Therefore, we also postulated that the level of pro-inflammatory gene expression by the diaphragm would be greater than in the limb muscles under the same conditions of P. aeruginosa infection. Finally, we hypothesized that pro-inflammatory mediator gene expression by the diaphragm, as well as associated diaphragmatic weakness, could be beneficially modulated by shifting the systemic balance between pro-and anti-inflammatory cytokines in favor of the latter through the use of IL-10 therapy.
MATERIALS AND METHODS

Animal model
The model of pulmonary infection with P. aeruginosa employed in this study was performed essentially as described by Starke and colleagues (24) , with minor modifications. A mucoid strain of P. aeruginosa (strain 508) was used, which was originally isolated from a cystic fibrosis patient (25) .
Briefly, log-phase P. aeruginosa bacteria were concentrated and mixed with 1.5% trypticase soy agar pre-warmed to 52 o C. This mixture was added to heavy mineral oil at 52 o C and rapidly stirred for 6 min, followed by cooling for 10 min at 4 o C. After removing excess oil, the bacteria-bead preparation was washed extensively and resuspended in sterile phosphate-buffered saline (PBS) at pH 7.4. The size (100-150 µm) and uniformity of the beads were verified by light microscopy. In addition, the number of viable bacteria trapped within the agar beads was measured by homogenizing the beads and then plating 10-fold serial dilutions on trypticase soy agar plates. Sterile agar beads were produced in the same manner but with omission of bacteria, and were confirmed to be free of colony-forming units (cfu). To deliver bacteria-containing agar beads to mouse lungs, the mice were first anesthetized with a combination of ketamine (130 mg/kg) and xylazine (20 mg/kg) injected intramuscularly. A small incision was made at the midline of the neck in order to expose the trachea. The trachea was then intubated with a sterile flexible 22-ga cannula attached to a 1 ml syringe, which was used to inject 50 µl of the agar bead suspension into the lungs. Mice were infected with two different dose of bacteria: 2x10 5 cfu (Low-dose) and 1x10 6 cfu (High-dose).
Studies were performed in 8-10 week old C57BL/6 mice, which were used in accordance with the guidelines established by the Canadian Council on Animal Care. A total of 6 experiments involving 119 mice were performed. Outcome measures differed among experiments, but all outcomes were evaluated at 48 hours post-infection unless otherwise specified. The dosages of P. aeruginosa bacteria employed for inducing lung infection, the time point of evaluation, and the primary limb muscles (soleus and extensor digitorum longus) selected for comparison to the diaphragm were all based upon our previous study, which demonstrated preferential diaphragmatic weakness with high-dose but not low-dose infection under the same conditions (4).
Primary muscle cell culture
Primary diaphragmatic muscle cell cultures were established as previously described (26), using single living muscle fibers to isolate adult myoblast precursors (also known as satellite cells).
Briefly, excised diaphragm muscle strips from 8 week old mice were subjected to collagenase digestion (0.2% collagenase at 37 o C for 60 minutes), followed by trituration with heat-polished Pasteur pipettes of decreasing bore size to liberate individual fibers. The individual fibers were washed in Dulbecco's modified Eagle's medium (DMEM) and PBS, collected, and then transferred into Matrigel (Becton Dickinson, Franklin Lakes, NJ)-coated (1 mg/ml in DMEM) 6-well plates. All culture media contained 1% penicillin/streptomycin and 0.2% amphotericin B (Invitrogen, Carlsbad, CA). The cultures were maintained in DMEM with 10% horse serum and 0.5% chick embryo extract (MP Biomedical, Aurora, OH) for 4 days, during which myoblasts attached to the substratum. Diaphragmatic myoblasts were then expanded in growth medium (20% fetal bovine serum, 10% horse serum, 1% chick embryo extract in DMEM) until attaining approximately 75% confluence. At this point, the cultures were placed in differentiation medium (2% fetal bovine serum, 10% horse serum, 0.5% chick embryo extract in DMEM) in order to induce myoblast fusion into differentiated myotubes.
IL-10 gene transfer and measurement of serum IL-10 levels
Construction of the recombinant adenoviral vector (Ad5E1mIL-10), containing the murine IL-10 cDNA driven by the human cytomegalovirus promoter, has been previously described in detail (22) .
For in vitro transduction studies, primary diaphragmatic myoblasts were expanded in growth medium for 48 hours and then transduced with Ad-IL-10 or empty vector contained in DMEM (multiplicity of infection = 20; 3.5 x 10 7 cells/well), for 4 hours. The myoblasts were then washed with PBS and maintained in growth medium for another 24 hours before being harvested for RNA extraction.
For in vivo studies, Ad-IL-10 (1x10 8 pfu) was diluted in 100 µl PBS and injected intramuscularly into the hindlimbs (two injection sites per leg, 25 µl per site) at the time of lung infection (22) . This method allows for more sustained elevations of IL-10 levels than can be achieved with single injections of recombinant protein, and the vector/gene dosage used in our study was based upon previous work using the same approach in a mouse endotoxemia model (22 
Evaluation of pro-inflammatory mediator expression levels
RNase protection assays (RPAs) were employed to quantify tissue mRNA levels. Samples of total RNA were isolated from mouse tissues using Trizol Reagent (Invitrogen, Carlsbad, CA). 32 Plabelled riboprobes were synthesized using a commercial mouse multiprobe kit (BD Biosciences, Pharmingen, San Diego, CA) containing templates against the following gene transcripts: iNOS, TNF-", IL-1", IL-1$, IL-6, and IL-18. The riboprobes were hybridized with each RNA sample overnight at 56 o C according to the manufacturer's instructions, using 20 µg of RNA for muscle tissues and 10 µg of RNA for the lungs and primary muscle cell cultures. The protected RNA fragments were separated using a 5% polyacrylamide gel and detected by autoradiography. Bands representing the individual mRNA species were then quantified using an image analysis system (FluorChem 8000, Alpha Innotech
Corp, San Leandro, CA), and the signals were normalized to the L32 housekeeping gene to control for loading in each lane. Commercial ELISA kits (R&D Systems) were employed to determine muscle tissue levels of selected cytokines as previously described (32) .
Bronchoalveolar lavage
The trachea was cannulated with a 22-ga catheter connected to two separate syringes via a three-way stopcock. One syringe was used to instill 5 ml of cation-free Hank's balanced salt solution (GIBCO, Burlington, Ontario) into the lungs, while the second syringe allowed the fluid to be collected by gentle aspiration. The total lavage fluid recovered was approximately 4 ml. Total cell numbers were determined using a hemocytometer. Differential cell counts were performed on cytospin preparations stained with Diff-Quick (American Scientific Products, McGaw Park, IL). From 300-400 cells were counted on each cytospin preparation, and the cells were classified as polymorphonuclear leukocytes, macrophages, and lymphocytes using standard morphological criteria.
Analysis of muscle contractile function
The diaphragm muscle was surgically excised for in vitro contractility measurements as previously described in detail (27) . After removal, the diaphragm was immediately placed into a chilled We have previously reported different contractility responses of the diaphragm and limb muscles (soleus and extensor digitorum longus) to lung infection with P. aeruginosa, with only the diaphragm showing significant muscle weakness at 48 hours after high-dose infection (4). Therefore, we also examined pro-inflammatory gene expression in the soleus muscle under the same conditions. In contrast to the diaphragm, high-dose P. aeruginosa infection did not significantly affect the level of proinflammatory cytokine expression in the soleus (see Fig. 2 ). The same results were obtained for two other limb muscles, the extensor digitorum longus and the tibialis anterior (data not shown). Figure 3A shows the effects of Ad-IL-10-mediated gene transfer upon IL-10 mRNA levels in cultured diaphragmatic muscle cells. As can be seen, myoblasts transduced with Ad-IL-10 exhibited strong IL-10 expression, whereas no detectable signal was obtained in cells infected with empty vector (i.e., lacking the IL-10 transgene). To determine whether adenovirus-mediated IL-10 gene transfer to muscle could modify serum IL-10 levels in vivo, mice in the high-dose infection group received Ad-IL-10 (1x10 8 pfu by i.m. injection) at the time of pulmonary inoculation. Mice identically treated with an empty adenoviral vector served as a control group. There was no detectable IL-10 protein by ELISA in the serum of uninfected CTL mice (data not shown). Figure 3B shows the levels of IL-10 present in the serum at different time points after high-dose P. aeruginosa infection. In mice treated with Ad-IL-10, serum IL-10 levels were maximal at day 1 and then began to taper off by day 2. Serum levels of IL-10 were detectable but significantly lower in the infected mice treated with empty vector, and did not differ between days 1 and 2. There were no differences in mortality between the infected mice treated with Ad-IL-10 or empty vector, and all animals were alive at 48 hours post-infection.
In vitro and in vivo expression of IL-10 and its receptor
To assess whether skeletal muscle is able to respond to IL-10 directly, we first determined by RT-PCR that the IL-10 receptor is expressed by diaphragmatic muscle in vivo as well as in cultured diaphragm muscle cells in vitro (Fig. 4A) . Cultured diaphragm muscle cells were then stimulated with cytokines (cytomix: TNF-α 2.5 ng/ml + IL-1α 25 U/ml), in the absence or presence of recombinant IL-10 treatment (50 ng/ml initiated one hour before adding cytokines). As shown in Fig. 4B , IL-10 treatment markedly suppressed the cytomix-induced upregulation of IL-6 mRNA expression, indicating that diaphragm muscle cells are capable of responding directly to the biological actions of IL-10.
Reduced pro-inflammatory cytokine expression and improved function of the diaphragm after IL-10 gene transfer
In mice with P. aeruginosa lung infection, analysis of BAL fluid revealed the expected large increase of inflammatory cell numbers (Fig. 5A ). Along these same lines, high-dose P. aeruginosa infection also led to marked upregulation of pro-inflammatory gene expression in the lungs with the exception of IL-6, which was not detected (Fig. 5B) . However, there was no significant effect of IL-10 gene transfer on either BAL cell number or the expression levels of inflammatory cytokines in the lung, when compared to identically infected mice treated with either empty vector or PBS injection.
Therefore, Ad-IL-10 treatment appeared to have little or no effect on the level of pulmonary inflammation in infected mice under these specific experimental conditions.
In contrast to the lungs, IL-10 gene transfer had a major effect in suppressing pro-inflammatory cytokine expression in the diaphragm during high-dose P. aeruginosa infection, as shown in Fig. 6 .
Empty vector had no significant effect on P. aeruginosa-induced cytokine upregulation in the diaphragm, as compared to PBS-treated animals with lung infection. On the other hand, mice treated with Ad-IL-10 exhibited a significant blunting of the mRNA upregulation normally found after high-dose P. aeruginosa infection for the following pro-inflammatory genes: TNF-" (79% reduction), IL-1" (72% reduction), IL-1$ (57% reduction), IL-6 (43% reduction), and IL-18 (46% reduction).
Therefore, with the exception of iNOS, all of the pro-inflammatory genes examined in the diaphragm during high-dose P. aeruginosa infection were downregulated by Ad-IL-10 treatment. These findings were confirmed at the protein level for IL-1" and IL-6, as shown in Fig 7. Finally, we wished to ascertain whether the above findings were associated with any alterations of diaphragmatic contractile function. Figure 8 illustrates the effects of Ad-IL-10 treatment on diaphragmatic force-generating capacity in the high-dose infection group. As we have previously reported (4), diaphragmatic force production was greatly depressed at 48 hours after high-dose pulmonary infection with P. aeruginosa in the control (empty vector) group. However, in mice which were identically infected and treated with Ad-IL-10, the force-generating capacity of the muscle was greatly ameliorated. This is indicated by major changes throughout the force-frequency relationship of the diaphragm shown in Fig. 8 , such that for any given electrical stimulation frequency, contractile force was significantly higher in the Ad-IL-10 group.
DISCUSSION
Skeletal muscle dysfunction, including that involving the diaphragm, is frequent in patients with chronic pulmonary disease. Because reductions in skeletal muscle mass and function are associated with increased morbidity as well as mortality in patients with chronic lung disease (28), there is a need to better understand this process and its possible link to pulmonary infection. In this study, our specific objectives were as follows: (1 The principal findings of our study can be summarized as follows: (1) Pro-inflammatory cytokine mRNA levels were highly induced within the diaphragm during P. aeruginosa lung infection, and this occurred in a bacterial dose-dependent manner; (2) Induction of cytokine expression did not occur in the limb muscle under the same conditions, indicating a preferential sensitivity of the diaphragm to cytokine upregulation by pulmonary infection; and (3) IL-10 gene transfer led not only to greatly attenuated cytokine upregulation within the diaphragm during P. aeruginosa lung infection, but also restored specific force generation of the diaphragm to normal levels. We also show for the first time that the IL-10 receptor is expressed by the diaphragm both in vitro and in vivo, and that diaphragm muscle cells have the ability to respond directly to IL-10.
Pro-inflammatory gene expression in the diaphragm during pulmonary infection
To our knowledge, this is the first study to specifically examine the effects of pulmonary infection on pro-inflammatory cytokine expression within the diaphragm. Most investigations of sepsis effects on skeletal muscle have been carried out in models of high-dose LPS exposure (5, 6, 30) .
However, the plasma cytokine profile in such models differs substantially from P. aeruginosa lung infection (31) . Furthermore, a potential advantage of the lung infection model is the presence of several characteristics which are closer to the usual clinical situation in patients, such as its more sustained nature, additional virulence factors within the bacteria beyond LPS alone, and a more complex interaction between infecting organism and the host immune response.
In our previous study employing this model (4), diaphragmatic force was reduced with highdose (1x10 6 cfu) but not low-dose (2 x10 5 cfu) infection, whereas limb muscle force was unaffected at both doses. These findings formed the basis for our hypothesis (confirmed in this study) that under the also be more vulnerable due to its greater inherent workload, and this difference would be further exaggerated during pulmonary infection due to an increase in the work of breathing. Indeed, it has recently been reported that even in the absence of sepsis, increasing the workload of the respiratory muscles causes significant upregulation of cytokines within the diaphragm (37) . Because an increased workload will increase blood flow to the muscle, this could also result in greater exposure of diaphragm muscle fibers to blood-borne pro-inflammatory effectors originating from other organs. The latter mechanism would be consistent with the findings of Li et al (38) , who reported that overexpression of TNF-α in the heart caused spillover of this cytokine into the systemic circulation, with attendant oxidative stress and contractile dysfunction of the diaphragm.
Implications for diaphragm muscle function
TNF-" has multiple effects on muscle, including the ability to directly inhibit force production (15), reduce protein synthesis (39), enhance protein degradation (40) , and destabilize myogenic transcription factors such as MyoD (41) . IL-1$ also inhibits muscle protein synthesis (12) . The role of IL-18 in skeletal muscle function is not clear, but its upregulation in cardiac muscle is associated with myocardial dysfunction (29, 42) . IL-6 upregulates the cathepsin as well as ubiquitin pathways of muscle proteolysis, and has been shown to induce atrophy of the diaphragm (10, 43) . Interestingly, while iNOS has been implicated in the pathogenesis of diaphragmatic contractile dysfunction in LPS models (6), iNOS mRNA levels in the diaphragm were not significantly modified by P. aeruginosa lung infection in the present study. This may have been due to the more chronic nature of our model and the later time point examined. Some of the adverse effects of cytokines on skeletal muscle cells may also be mediated through their common ability to activate the transcription factor NF-kB (44), which induces muscle wasting and a loss of intrinsic force-generating capacity when constitutively overactivated in muscle (45) . Overall, there is abundant evidence that increased levels of proinflammatory cytokines within skeletal muscle favor muscle wasting and weakness, particularly when multiple cytokine members are upregulated at the same time (44, 46) . Our findings further support this idea, since IL-10 treatment was able to largely abrogate cytokine gene upregulation in the diaphragm and simultaneously prevent diaphragmatic weakness.
To our knowledge, this is the first study to document the presence of IL-10 receptor expression both in primary muscle cell cultures obtained from the diaphragm and at the whole tissue level.
Moreover, the fact that recombinant IL-10 was able to directly suppress pro-inflammatory cytokine expression in cultured diaphragmatic cells exposed to putative sepsis mediators (TNF-", IL-1"),
indicates that the IL-10 receptor is functional in these cells. This is consistent with a prior report that IL-10 prevents IL-1"-induced intracellular adhesion molecule (ICAM)-1 expression by human myoblasts in vitro (47) . Taken together, these findings all suggest that the beneficial effects of IL-10 gene delivery on diaphragmatic cytokine expression and contractile function observed in our study are likely to have resulted, at least in part, from the direct local actions of IL-10 on diaphragm muscle fibers. In addition, it is entirely possible that IL-10 gene transfer exerted additional beneficial effects upon diaphragmatic function by suppressing systemic pro-inflammatory cytokine release from other organs (48, 49) . Therefore, while the relative importance of local versus systemic effects of IL-10 therapy on diaphragmatic function cannot be determined from our study, it is reasonable to speculate that both are likely to have played a significant role in the observed salutary effects.
Clinical Implications
Many patients with cystic fibrosis are chronically colonized with P. aeruginosa and suffer from repeated acute infectious exacerbations. The model used in our study has been used to mimic this scenario (25, 35) , although it should be recognized that it only approximates the endobronchial pathology found in patients. In animal models as well as humans, there is evidence that the balance between pro-and anti-inflammatory cytokines determines the severity of the systemic response to 
